News & Events - Page 9 of 21 - Bay City Capital

Filters

Portfolio News

April 15, 2016

Nevro Receives FDA Approval for New Surgical Leads for the Senza Spinal Cord Stimulation System

Portfolio News

April 14, 2016

Cydan Raises $31M in Series A Funding

Portfolio News

April 14, 2016

Madrigal and Synta Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company

Uncategorized

April 5, 2016

EnteroMedics Announces Publication of Results Showing Significantly Greater Weight Loss in vBloc Patients with Moderate Obesity

Portfolio News

April 5, 2016

Interleukin Genetics Announces Clarification of Commercial Test Compliance

Bay City Capital News

April 4, 2016

David Beier Forbes Op-Ed Calls for Closer US-China Collaboration in Life Sciences

China And the U.S.: Come Together Right Now Over Life Sciences

Portfolio News

March 29, 2016

Interleukin Genetics Announces Study to Evaluate Impact of PerioPredict on Patient Engagement and Preventive Care

Bay City Capital News

March 29, 2016

David Beier And Andrew Sullivan OpEd on Occupational Licensing

Easing Licenses is a Bipartisan Way to Boost Jobs

Bay City Capital News

March 28, 2016

David Beier Comments in The Hill on Communications Privacy Reform for Email

Preserving Email Privacy Requires Closing a Loophole, and Not Creating Another

Portfolio News

March 17, 2016

Reset Therapeutics, Inc. Establishes Research Collaboration With Alkermes

Portfolio News

March 17, 2016

Interleukin Genetics Appoints Global Clinical Advisory Board

Portfolio News

March 9, 2016

Merus Announces Issuance of Three U.S. Patents

Bay City Capital News

March 7, 2016

David Beier On The Value of Innovation: An RPM Report Op-Ed

Portfolio News

March 3, 2016

Omicia Announces Appointment of Matt Tindall as Chief Executive Officer

Portfolio News

February 29, 2016

Dermira Completes Patient Enrollment for DRM04 Phase 3 Pivotal Trials in Primary Axillary Hyperhidrosis